1. Estimation of the Effective Dose of Patient in Interventional Radiology: Study of Coronary Angiography
- Author
-
Atsushi Fukuda, Mayumi Hayakawa, Hiroto Nakagawa, Akira Chadani, Kimiya Noto, Kousuke Matsubara, Chikako Kawabata, Hiroji Iida, and Kichirou Koshida
- Subjects
Coronary angiography ,medicine.medical_specialty ,medicine.diagnostic_test ,Phantoms, Imaging ,business.industry ,Interventional radiology ,General Medicine ,Coronary Angiography ,Radiation Dosage ,Radiography, Interventional ,Effective dose (radiation) ,Imaging phantom ,Acrylates ,Dose area product ,Conventional PCI ,medicine ,Humans ,Fluoroscopy ,Thermoluminescent Dosimetry ,Thermoluminescent dosimeter ,Radiology ,business ,Nuclear medicine - Abstract
The applications of interventional radiology (IVR) increasingly are being used in clinical examinations, where they tend to extend examination time. In addition, the risk of occupational exposure necessarily is increasing with this technology. In this study, the dose distributions in a sliced acrylic-acid phantom involving the bore for each irradiation condition were measured using a thermoluminescence dosimeter (TLD). Four patterns of set-up for the fluoroscopy unit were chosen as references for the conditions generally used clinically. Exposure also was measured with dose area product (DAP), and we then calculated the entrance skin dose and effective dose for the patient. The results showed that the effective dose was 7.0 mSv to 8.0 mSv at LAO45 degrees and RAO30 degrees; 100 kV, 2.3 mSv to 3.3 mSv at LAO45 degrees and RAO30 degrees; 80 kV. The effective dose is greatly influenced by the setup of fluoroscopy in IVR. The change in DAP is especially influenced. We found that the relation between DAP and effective dose was corrected with the exponential function. The effective doses were not necessarily less than those of other radiation examinations, and increase. When PCI and TAE are repeated many times in IVR, we propose that the effective dose should be taken into consideration together with the skin dose for dose control management.
- Published
- 2006
- Full Text
- View/download PDF